Autopsy report · NCT05658029

An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy

“Terminated due to enrollment challenges”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Matthew Bruehl

Sponsor type

University, hospital or other

Conditions

Tracheostomy

Interventions

ARINA-1

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
  “Terminated due to lack of enrollment” (89% match in meaning)
• Polycystic Liver Disease in Kidney Transplant
  “Terminated due to inadequate enrollment” (88% match in meaning)
• Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
  “terminated due to poor enrollment” (88% match in meaning)
• Feasibility Study on LITT for Newly Diagnosed Glioblastoma
  “Terminated (failure to enroll)” (85% match in meaning)
• Alphanate in Immune Tolerance Induction Therapy
  “Terminated due to limited enrollment (non-safety related decision)” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.